Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8414893 Anti-amyloid antibodies and uses thereof

Patent 8414893 was granted and assigned to Amgen on April, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 29 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 29 Nov, 2023
Edits made to:
Article (+327 characters)
Article

Patent abstract

Compositions for treating neurodegenerative or amyloidogenic disorders such as Alzheimer's disease (AD) are provided. More particularly, anti-amyloid-beta antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.

Edits on 11 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11780912 Composition for prophylaxis or treatment of IL-8 related diseases
Edits on 24 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11654193 Cancer treatment combinations
0
Edits on 20 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08414893 Anti-amyloid antibodies and uses thereof US Patent 8414893 Anti-amyloid antibodies and uses thereof

Infobox
Patent Number
0841489300
Patent Number
841489300
Edits on 27 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
084148930
Date of Patent
April 9, 2013
0
Patent Application Number
128095630
Date Filed
December 19, 2008
0
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
0
Edits on 27 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
084148930
Date of Patent
April 9, 2013
0
Patent Application Number
128095630
Date Filed
December 19, 2008
0
Patent Primary Examiner
‌
Elizabeth C. Kemmerer
0
Edits on 16 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 16 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08414893 Anti-amyloid antibodies and uses thereof

Infobox
Is a
Patent
Patent
Current assignee
Amgen
Amgen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08414893
Date of patent
April 9, 2013
Patent application number
12809563
Date Filed
December 19, 2008
Patent primary examiner
‌
Elizabeth C. Kemmerer

Find more entities like US Patent 8414893 Anti-amyloid antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.